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Lemur Tail (former tyrosine) Kinases (LMTKs) comprise a novel family of regulated 
serine/threonine specific kinases with three structurally and evolutionary related members. LMTKs 
exercise a confusing variety of cytosolic functions in cell signalling and membrane trafficking. 
Moreover, LMTK2 and LMTK3 also reside in the nucleus where they participate in gene 
transcription/regulation. As a consequence, LMTKs impact cell proliferation and apoptosis, cell 
growth and differentiation, as well as cell migration. All these fundamental cell behaviours can turn 
awry, most prominently during neuropathologies and tumour biogenesis. In cancer cells, LMTK levels 
are often correlated with poor overall prognosis and therapy outcome, not least owned to acquired 
drug resistance. In brain tissue, LMTKs are highly expressed and have been linked to neuronal and 
glia cell differentiation and cell homeostasis. For one member of the LMTK-family (LMTK2) a role in 
cystic fibrosis has been identified. Due to their role in fundamental cell processes, altered LMTK 
physiology may also warrant a hitherto unappreciated role in other diseases, and expose them as 
potential valuable drug targets. 
 
On the backdrop of a compendium of LMTK cell functions, I hypothesize that the primary role of 



































1. Introduction: Salient features of LMTK-family kinases 
 
All living organisms use protein modifications in order to adjust and regulate cell behaviour 
in response to external cues. Protein kinases are one such class of modulators that help to 
coordinate multi-tiered intracellular signalling and transport pathways by adding a phosphate group 
to their specific substrates. Phosphorylation causes conformational changes in the respective 
molecules leading to changes in their binding specificity and/or affinities. Phosphorylation often 
regulates plasma membrane residency and abundance of proteins/receptors through multiple 
endocytic pathways. 
 
Interestingly, amino acid sequence alignments and evolutionary pedigree analysis have 
classified kinases into distinct families, e.g. the cell surface receptor tyrosine kinase (RTK) family, an 
intensively investigated group [1]. Less highlighted but nevertheless highly conserved, places the 
three members comprising Lemur Tail (former Tyrosine) Kinases (LMTKs) at a more recent branch of 
kinase evolution. 
 
All LMTKs feature a short N-terminal segment followed by a kinase domain and a long C-
terminal tail, taking their name in reference to the long tail of Lemurs (Figure1) [2]. Sequence 
analysis and experimental evidence indicate a N-terminal signal peptide and a transmembrane (TM) 
region. Indeed, topological studies using fluorescence protease protection experiments concluded 
that LMTK2 is an integral membrane protein with two transmembrane domains, positioning both the 
N-and C-terminals in the cytoplasm [2, 3]. 
 
Similar studies for LMTK1 and LMTK3 have not been conducted; therefore, their exact 
membrane topology remains elusive. However, LMTK1 is subjected to alternative splicing giving rise 
to two isoforms, LMTK1A without and LMTK1B with a presumed transmembrane domain [3]. 
However, three palmitoylated cysteines have been identified that localise LMTK1A to intracellular 
vesicle membranes of transferrin positive recycling endosomes in cortical cultured neurons and COS-










The short N-terminal region is followed by a highly conserved kinase domain, initially 
suggestive of tyrosine kinase activity that had been deduced from sequence homology with other 
known tyrosine kinases [5]. However, in vitro pepscan, using the LMTK2 kinase fold attached to its 
adjacent proposed specificity conferring C-terminal segment, revealed that phosphorylation activity 
is strictly restricted to serine/threonine residues that are either preceded or followed by proline 
residues [6]. 
 
Another specific feature shared by LMTKs relates to their long C-terminal proline-rich region 
 
[5]. Additionally, LMTK3 contains three novel distinctive poly-proline motives whose function is 
unknown. Embedded in these poly-proline regions X-proline-proline-X-proline (where X represents 
an aliphatic amino acid) motifs are found that potentially can interact with SRC Homology 3 Domain 
(SH3) containing proteins. The SH3 interactome revealed that SH3 domain containing proteins 
significantly participate in endocytosis but also in the remodelling of the cytoskeleton and in signal 
transduction pathways [7, 8]. 
 
There is an abundance of recent review articles that provide comprehensive summaries of the 
many examples of RTKs that undergo nuclear translocation [9]. In silico sequence analysis predicts nuclear 
localisation and export signals for both LMTK2 and LMTK3. Indeed, although both kinases are 
predominantly part of cytoplasmic endomembranes, they are also detected in the nucleus (see below) 
 
[10]. Physiological relevance to nuclear localisation was given recently to LMTK2-androgen receptor 
(AR) complexes that reside in the nucleus (see below) [10]. In addition, it was found that under 
importin 1 knockdown conditions, nuclear levels of LMTK3 were reduced concomitant with 
increased cytoplasmic levels [11]. Subsequently, chromatin- immunoprecipitation experiments 
revealed chromatin association of LMTK3. These data together are suggestive of a role of either 
LMTK proteins in chromatin scaffolding and/or receptor mediated specific gene regulation [10, 11]. 














Mechanisms that lead to nucleocytoplasmic equilibrium have yet to be untangled. For 
instance, it remains an intriguing question whether similar to RTKs, auto phosphorylation and/or 
protein cleavage occurs in spatiotemporal regulation of LMTKs (see below). 
 
LMTK2 and LMTK3 but not LMTK1 knockout mice have been generated [12, 13]. LMTK2 -/-
and LMTK3 -/- mice are viable and grossly normal suggesting that either protein is dispensable for 
embryonic and postnatal survival, however LMTK2 knockout mice produce sterile male progenies 
through the inhibition of spermatogenesis [13]. It is not known whether partly functional 
redundancy or other compensating mechanisms cause non-essentiality. 
 
Finally, each LMTK family member has been described independently in different 
laboratories giving rise to multiple synonyms for each of the three LMTKs (see www.uniprot.org). 








Substrate specificity and spatio-temporal regulation is a pivotal characteristic of all kinases. 
Regulation often involves additional upstream acting kinases. In addition, substrate-binding kinases 
often summon molecules that together orchestrate particular transduction pathways. 
 
2.1. LMTK substrates 
 
 
To date, LMTK2 has been reported to bind to and phosphorylate threonine 320 of the 
serine/threonine protein phosphatase 1C (PP1C), a phosphatase often associated with its role in the 
turnover of membrane proteins/receptors [14]. Binding of PP1C to LMTK2 utilises a valine-threonine-
phenylalanine motif in LMTK2. Cyclin-dependent kinase 5 (Cdk5) increases the phosphorylation activity of 
LMTK2 to PP1C that in turn attenuates PP1C phosphatase activity (see below) [14]. Additionally, PP1C is 












to PP1C [6]. Since PP1C has manifold cellular targets, LMTK2 regulation of PP1C/Inh-1 triggers 
coordinated responses affecting different targets and pathways, simultaneously. 
 
Serine737 of cystic fibrosis transmembrane conductance regulator (CFTR) has also been 
described as another LMTK2 phosphorylated residue modulating residency and recycling of CFTR at 
the plasma membrane [see below) [15]. 
 
With the caveat of having used solely the kinase domain of LMTK3, estrogen receptor alpha 
 
(ER ) has been identified as a LMTK3 substrate, although the phosphorylated amino acid residue has 
not yet been determined and the verification of the obtained in vitro results with a more complete 
recombinant LMTK3 protein is still pending [16](Figure 2). 
 
Although not directly proven, LMTK3 loss-of-function experiments suggested that 
hepatocyte growth factor (HGF) induced LMTK3-dependent phosphorylation of serine 435 in Rab-
Coupling Protein (RCP), a Rab11/14 GTPase effector protein involved in endocytic recycling [17]. 
 
Interestingly, amino acids juxtaposed to the LMTK2 in CFTR and LMTK3 in RCP 
phosphorylation sites show a high degree of sequence similarity (peptide corresponding to CFTR 
residues 733–741 (ERRLpSLVPD) and 430-443 RCP (ESRRSpSLLSLMTGK). Whether this is an indication 
for functional redundancy has not yet been scrutinised. Moreover, it is unknown whether additional 
substrate specific phosphorylation sites exist for either kinase [15, 17]. 
 
It has been reported that both LMTK1 and LMTK2 can also undergo autophosphorylation 
specifically on serine/threonine residues. In granule cells, LMTK1 becomes hypophosphorylated under 
depolarising culture conditions and hyperphosphorylated under apoptosis inducing conditions [18]. 
Mutations in serine 480, serine 558, and serine 566 suppressed hyperphosphorylation and apoptosis 
suggesting an involvement of these residues in apoptotic functions. In vitro experiments with LMTK2 
kinase domain also revealed autophosphorylation, however, the identification of the affected residues 












autophosphorylation. This autophosphorylation of LMTKs is a feature reminiscent of RTKs that 
undergo autophosphorylation upon pathway induction. 
 
Finally, no direct substrate has as yet been determined for LMTK1. However, based on the 
conserved primary structure of the kinase domain, the assumption holds that serine/threonine 
specificity extends to all LMTK members including LMTK1. 
 
2.2. Scaffolding functions of LMTKs 
 
 
Despite substrate binding/phosphorylation, LMTKs can also serve as scaffolds that assemble 
regulatory and other molecules that act in concert leading to a common response. 
 
One prominent example for a scaffolding function of LMTKs is exhibited by LMTK1. It has 
been suggested that LMTK1 inhibits the activation of the plasma membrane, osmoregulator Na-K-2Cl 
cotransporter, NKCC1, by scaffolding the inhibitory protein phosphatase 1 (PP1) in close proximity to 
the stimulatory serine-threonine kinase SPAK/WNK4, hence resulting in the dephosphorylation of 
SPAK [19, 20]. While the kinase activity of LMTK1 was dispensable for PP1 suppression of NKCC1 
function, binding of LMTK2 led to the phosphorylation- mediated regulation of PP1C activity (see 
above). The discrepancy in the physiological role of kinase activity of LMTKs warrants future studies 
in the exact mechanisms of ATP binding/hydrolysis. 
 
2.3. Interaction of LMTKs with regulatory kinases 
 
 
Kinases as part of tiered signalling are often subjected to regulation that ultimately connect with 
intrinsic or external cavalcades. Several upstream kinases have been shown to affect and regulate LMTK 
kinase activities. Accordingly, LMTK1A and LMTK2 bind to the cyclin-dependent kinase (CDK5) activator 
protein p35 [14, 21]. P35 although preferentially expressed in neurons, is, however, also expressed in the 
breast cancer cell line MCF-7 (Wendler, unpublished data). LMTK1 and LMTK2 can undergo Cdk5/p35 
dependent phosphorylation, with Serine 34 in LMTK1 and serine 1418 in LMTK2 












LMTK1 and 2 is placed on the C-terminal side adjacent to the kinase domain. However, the actual 
Cdk5 phosphorylation sites in LMTK1 and LMTK2 are located on opposite ends of the respective kinases. 
This fact renders it rather inconceivable that both Cdk5 phosphorylation sites are functionally related. 
 
In silica analysis predicts additional CDK5 consensus phosphorylation sites in either protein and also 
in LMTK3. However, no evidence has been reported for Cdk5-dependent LMTK3 phosphorylation. 
 
The non-RTK Src, a protein required for the internalisation of integrins and RTKs, focal 
adhesion turnover, and cell spreading and migration, was described as a kinase with potential 
regulatory function for LMTK1A [4, 22]. Src kinase directly interacts with N-palmitoylated LMTK1A 
and phosphorylates tyrosine 25 and tyrosine 46 juxtaposing the Cdk5 phosphorylation site at serine 
34 [4]. It has been speculated that Cdk5 dependent phosphorylation prevents Src dependent 
phosphorylation and vice versa, regulating endocytic vesicle flow in axonal and dendritic cell 
protrusions [23]. 
 
Myosin VI, a plus-to-minus directed, actin-based, unconventional motor protein that acts in 
retrograde membrane transport interacts with LMTK2. A region, close to the kinase domain of 
LMTK2 that overlaps with CDK5/p35 binding, binds to the WWY motif containing C-terminal segment 
of myosin VI that in turn can also bind to disabled homolog 2 (Dab2), an adapter protein linking 
endocytosis with the cytoskeleton [24, 25]. The potential mechanistic relationship between LMTK2, 
CDK5/p35, myosin VI and potentially Dab2 in vesicle selection/transport remains to be interrogated. 
 
Finally, the investigation of nuclear functions of LMTK3 revealed KRAB-associated protein 1 
(KAP1) as a binding partner (see below) [11]. 
 
In conclusion, activities of LMTKs are subjected to regulation, by regulators such as Cdk5/p35 
and Src, important players during cell differentiation. Moreover, binding proteins have been 
identified that link LMTKs to protein transport. Therefore, LMTKs might serve as regulated platforms 

















Engagement of plasma membrane cargo with the intracellular transport machinery depends 
on the binding of pathway-specific adaptor molecules and coat proteins. Cargo modification such as 
phosphorylation plays a pivotal role in this process and in some instances triggers internalisation. 
 
Co-localisation studies with Rab5 (EE, early endosome), Rab11 (RE, recycling endosome), 
and Rab7 (LE, late endosome) established that LMTK1-3 are integral to endosomal recycling but not 
to late endosomal/lysosomal degradation pathways (Figure 3). In addition, the LMTK regulators Src 
and Cdk5/p35 have been linked to endosomal vesicle transport [26, 27]. Therefore, it stands to 
reason that LMTK kinase activities may select/modulate substrate recycling. For instance, data from 
Cos-7 cells indicate that LMTK1A associates with p35 in early and recycling endosomes. Moreover, in 
PC12D cells, nerve growth factor (NGF) stimulated Cdk5/p35 dependent phosphorylation that in turn 
inhibited Src dependent tyrosine phosphorylation of LMTK1A suggesting a Cdk5/p35 Src interplay 
[23]. Subsequent reports by Takano et al placed LMTK1A upstream of Rab11A, regulating endocytic 
recycling in CHO-1 and mouse cortical neurons (see below) [28, 29]. 
 
LMTK2 is part of the signalling cascade leading to kinesin-1 dependent anterograde transport of 
axonal cargo along microtubules. Kinesin-1 is a heterotetrameric protein complex consisting of two 
 
identical motor protein subunits and two “light chains” (KLC). Glycogen synthase kinase-3β (GSK3 
binds and phosphorylates un-phosphorylated KLC thus releasing cargo, which includes synaptic 
vesicles, amyloid precursor protein (APP) or other proteins such as mothers against decapentaplegic 
homolog 2 (Smad2) transcription factor, whose presence shifts from the cytoplasm to the nucleus 
 
upon TGF [30].  
 
 
The TGF is manifoldly implicated in cell-fate determination and tissue re-  
 
generation. It has been reported that in a chain of events, Cdk5/p35 phosphorylates LMTK2 at serine 










leads to enhanced inhibitory phosphorylation of GSK3β at serine 9 [14]. Inhibited GSK3β is no longer 
 
able to phosphorylate KLC leading to premature Smad2 release. Altered TGF /Smad2 signalling 
affects a wide range of cellular processes including the regulation of cell division and apoptosis, 
differentiation, and cell migration [31, 32]. 
 
As discussed above, LMTK2 physically interacts with myosin VI. Both LMTK2 and myosin VI 
have been attributed to EE and tubular RE suggesting that LMTK2 and myosin VI might act together 
in consecutive parts of the early recycling pathway, i.e. from the plasma membrane (PM) to the EE 
and the RE compartment. 
 
For instance, apical PM surface density of CFTR, an ATP-gated anion channel depends on 
both LMTK2 and myosin VI [15]. Studies in human bronchial epithelial cells (HBE) revealed that 
endogenous LMTK2 physically interacts and phosphorylates CFTR (serine 737) at the apical cell 
membrane. Expressing a kinase domain truncated form of LMTK2 abolished this phosphorylation and 
consequently decreased CFTR internalisation. In addition, depletion of either myosin VI or LMTK2 
resulted in a significant decrease in the recycling of CFTR to the PM [24]. LMTK2 regulation of CFTR 
recycling has severe physiological implications affecting CFTR-mediated chloride secretion in mice 
and human. 
 
Interestingly, myosin VI not only acts in endocytic recycling but also displays nuclear functions 
through the binding to and the activation of RNA-polymerase II [33, 34]. Since the myosin VI-binding 
partner LMTK2 also partly resides in the nucleus, it will be of interest whether their functional 
relationship also extends to gene transcription regulation. In this context, it is noteworthy that LMTK2-
androgen receptor (AR) complex is also detected in the nucleus, prompting the question for the existence 
of a tri-partite AR-LMTK2-myosin VI complex that could trigger the onset of AR specific gene 
transcription [10]. Nuclear myosin VI localisation is also crucial for ER dependent regulation of gene 
 














whether a tri-partite LMTK3/myosin VI/ ER x exists and triggers transcriptional gene  
 
activation. However, LMTK3/myosin VI interaction has not been reported. 
 
 
In conclusion, it will be of the utmost interest to understand the functional relations of 
LMTK2/LMTK3 with motor proteins such as myosin VI or possibly other cytoplasmic/nuclear myosins also; 
how they relate to each other and how nucleocytoplasmic distribution is achieved and regulated. 
 
Another line of evidence suggested that LMTK3 might directly modulate endocytic trafficking 
by the phosphorylation of endocytic trafficking regulators. It was found that upon hepatocyte 
growth factor induction, LMTK3 phosphorylates the Rab11/14 effector protein RCP in H1299 cells, a 
non-small cell lung cancer cell line. Thereupon, phosphorylated RCP engages with Rab14 positive 
recycling vesicles that carry RTK ephrin receptor A2, shunting it to an alternative recycling pathway 
back to the PM that ultimately leads to cell:cell repulsion and enhanced cell migration [17]. 
 
Finally, cultured primary neuronal cells obtained from LMTK3 knockout mice accumulated 
Glu2NB-containing NMDA receptors that are preferentially transported through the endosomal 
recycling pathway. Although AP2 binding to LMTK3 was observed, it was not determined whether 
the AP2 or the NMDA receptor additionally become LMTK3 phosphorylated during transport [12]. 
 
To summarise, we conclude that LMTKs prime different proteins for intracellular transport. 
Their exact function in cargo selection/sorting remains elusive. However, the involvement of LMTKs 
in endocytic trafficking warrants a multitude of pleiotropic downstream consequences for cell 




4. Neuronal cell functions of LMTKs 
 
 
All LMTKs are highly expressed in brain tissue of the cortex, hippocampus and cerebellum. 
Consequently, all three family members have been reported to execute physiological functions in 










The major isoform of LMTK1, LMTK1A, is implicated in dendritic formation and anterograde 
membrane delivery during neurite outgrowth [29]. Cdk5/p35 that is highly enriched in neuronal cells 
plays a pivotal role in both these processes. In axons of C. elegans, a kinase-ablated form of Cdk5 
promotes neurite outgrowth consistent with results obtained in cells with diminished LMTK1A levels, 
or where a form of LMTK1A in which the Cdk5/p35-phosphorylation site was mutated to an alanine 
is expressed [28, 29, 36]. Thus LMTK1A functions as a negative regulator of neurite outgrowth. 
Accordingly, primary neurons obtained from LMTK1A -/- mice increased the prevalence of 
anterograde transport of Rab11A positive vesicle membranes to the sites of growth. 
 
However, contrasting results have been obtained in immature granule cells where 
overexpression of wild-type LMTK1A promoted and a kinase-defective mutant significantly inhibited 
neurite outgrowth suggesting a positive regulatory function for LMTK1A. On the same note, 
experiments in cerebellar and cortical neurons, and in retinal ganglion cells conclude that Cdk5/p35 
inhibition can reduce neurite length [37-39]. Context specific roles of LMTK1A may explain these 
contrasting results and promote future research in the exact mechanistic relationship between both 
Cdk5/p35 and LMTK1A. 
 
Despite its role in neuronal cell differentiation, overexpression of LMTK1 led to enhanced 
apoptotic cerebellar granule cells, which suggests a role in the establishment of proper neuronal 
connectivity during brain development and aging. 
 
LMTK1 functions, however, are not only restricted to neuronal cells as its upregulation has 
also been detected during oligodendrocyte differentiation. It has been speculated that enhanced 
LMTK1A levels during differentiation could lead to the modulation of the levels of GPR17, a G-
protein coupled receptor at the cell surface, through reduced degradation and enhanced receptor 
















LMTK2 was also identified as a negative regulator, which when introduced as a kinase dead 
version into PC12 cells, enhanced neurite outgrowth during NGF induced neuronal cell 
differentiation, suggesting a role in NGF-TrkA signalling [41]. 
As discussed further above, LMTK2 also participates in the TGF /Smad2 signal transduction 
 
chain leading to the expression of TGF -responsive genes that are instructive during neuronal cell 
 
development [42]. In an Alzheimer’s disease tau mouse model, impeded TGF Smad2 transport can 
be traced back to decreased LMTK2 expression levels. Furthermore, it has been speculated that 
decreased LMTK2 levels and/or kinase activity could potentially lead to aberrant tau 
 
hyperphosophorylation due to elevated GSK3 (excellently discussed in [43])  
 
 
Functional/mechanistic studies linking LMTK3 functions to neuronal cell development are 
limited. Primary neurons obtained from wild type and LMTK3 -/- knockout mice have not shown any 
significant difference in axon length and arborisation of dendrites. Most interestingly, however, mice 
lacking LMTK3 displayed significant behavioural differences compared to the control group, including 
hyperlocomotion, reduced anxiety and depression-like behaviour. Abnormal behaviour was 
supported by the increased turnover of dopamine and chemical imbalance in the brains of deficient 
mice, a phenomenon associated with decreased anxiety [12] 
 
To summarise, we conclude that all three LMTK kinases exhibit functions during neuronal 
development that are maintained throughout adulthood. Moreover, imbalanced/decreased LMTK 
function/levels may play a part in neurodegenerative pathologies. 
 
5. LMTKs and Cancer 
 
 
As LMTKs play a part in intracellular trafficking, signalling and gene expression, it is not 
surprising that changes in their physiological levels/activities impact cell behaviour, including cell 















A wealth of cancer related publications reported alterations in LMTK expression/protein 
levels. Accordingly, tumour cells derived from different tumour types can correlate either positively 
or negatively with LMTK expression/protein levels suggesting context specificity. Due to the overall 
low cellular abundance of LMTK proteins in cells including cancer cells, correlation is often based on 
mRNA levels, which might not necessarily correspond to translated protein: mRNA levels might be 
subjected to altered regulatory mechanism in the respective cancer cell context. 
 
Consequently, much of the available experimental evidence describing a role of LMTKs in 
cancer cells is based on either loss-of- and/or gain-of- function (GOF) experiments whereas 
endogenous LMTK protein escapes detection. Results solely based on GOF experiments might 
produce new aberrant phenotypes and often skew the conclusions therefore. 
 
With this framework in mind, I will focus on the cell physiological consequences caused by 
altered LMTK levels and/or functions. 
 
Univocally, elevated levels of Src activity has been linked to cell growth during cancer 
progression promoting cell proliferation and survival, angiogenesis, and migration/invasion pathways 
in colon, liver, lung, breast, pancreas tumours and metastatic melanoma. Signal transduction 
pathway analysis in metastatic melanoma cell lines revealed an inverse correlationship between 
LMTK1 expression levels and activated Src. Occuring lower LMTK1 mRNA levels in metastatic 
melanoma cell lines led to increased levels of activated Src protein, whereas ectopic overexpression 
of LMTK1 in primary and metastatic derived melanoma cell lines decreased activated Src levels. 
Consequently, abrogated LMTK1 levels promoted cell migration while its overexpression resulted in 
a modest inhibition of cell proliferation and colony formation. Importantly, apoptosis was promoted 
when either LMTK1 overexpressing cell line was grown in phosphate-buffered saline alone 
suggesting a a role for LMTK1 in mediating coordinated cellular responses to nutrient supply [44]. 
However, no physical association between LMTK1 and Src has been detected in melanoma cells 











LMTK2 is frequently mutated in lung adenocarcinoma and pulmonary sarcomatoid 
carcinoma [45, 46]. In addition, single-nucleotide polymorphisms (SNPs) in the LMTK2 gene have 
been identified in colorectal adenocarcinoma and prostate cancer that increases the susceptibility 
for prostate tumours more significantly in Asian men cohorts [47]. 
 
LMTK2 protein levels are also often down-regulated in human prostate cancer tissue in 
comparison to adjacent non-cancerous tissue [48]. One potential mechanism by which down-
regulated LMTK2 may increase the susceptibility for prostate cancer might involve the regulation of 
AR functions. Under androgen-deprived conditions, LMTK2-AR complexes are found primarily in the 
cytoplasm. In the presence of the synthetic androgen, R1881 AR-LMTK2 complexes are also detected 
in the nucleus (see also above). Furthermore, experiments in the androgen-dependent prostate 
cancer cell line, LNCaP, indicated that loss of LMTK2 results in ligand enhanced transcription of 
androgen-responsive genes professed to reduce AR degradation and enhanced transcription [10]. 
 
Nevertheless, the exact mechanisms through which LMTK2 affects AR responses remain 
unknown. The further above discussed Cdk5/p35 dependent LMTK2 regulation of PP1C phosphatase 
activity might provide a promising link. AR-responsive genes are upregulated under LMTK2 depletion 
conditions. On the other hand, PP1C-dependent dephosphorylation of serine 650 in AR causes a 
decrease in AR-transcriptional activity. Since LMTK2 phosphorylation of PP1C leads to PP1C 
phosphatase inhibition, these discordant results prevent an obvious LMTK2/ PP1C link in the 
regulation of AR activities [49]. 
 
Lastly, LMTK2 silencing also increased the sensitivity of immortalized epithelial and cancer 
cells to TNF-related apoptosis-inducing ligand (TRAIL) treatment through down-regulation of the 
BCL2-family anti-apoptotic proteins and the reciprocal up-regulation of the pro-apoptotic protein in 















Ample data have been gathered implying LMTK3 as a survival factor in different forms of 
cancers. For instance, LMTK3 has been identified as a positive regulator in the Wnt3a induced 
Wnt/β-catenin signalling cascade but has not been further investigated [50]. Deregulated Wnt/ β-
catenin signalling contributes to the progression of various cancers including colorectal, 
hepatocellular carcinoma and breast cancer [51]. 
 
Furthermore, a siRNA kinome screen identified LMTK3 as a positive regulator of ERα-
dependent transcriptional activity in MCF-7 breast cancer cells [16, 52]. LMTK3 enhances both ERα 
expression and protein stability presumable through direct phosphorylation of ERα. Interestingly, 
this places LMTK3 in analogy to LMTK2 for a role in steroid hormone receptor stability/-dependent 
gene regulation (Figure 4). 
 
LMTK3 is also often indirectly involved in numerous cellular signalling pathways, although 
the exact mechanisms by which regulation is achieved often remains obscure. For instance, Giamas 
et al drew a model in which LMTK3 acts by decreasing protein kinase C (PKC)-dependent kinase B 
(PKB/AKT) phosphorylation and activity that also contributes to ERα stability. Additionally, decreased 
PKB/AKT prevents forkhead box O3 (FOXO3) degradation. As a consequence FOXO3 stability is 
enhanced leading to an upregulation of ERα-gene expression [16]. 
 
Finally, overexpression of LMTK3 in the low LMTK3 expressing breast cancer cell line led to a 
chain of events that ultimately resulted in enhanced transcription factor serum response factor (SRF), and 
induced increase of integrin α5 and β1 subunits expression. Changes in the cytoskeleton promote 
invasive cell behaviour, thus it was delineated that integrin subunit expression was dependent on LMTK3 
interaction with growth factor receptor-bound protein 2 (GRB2). Interaction activated CDC42 Rho family 
guanosine triphosphatase that in turn promoted the RAS downstream signalling cascade, eventually 
increasing gene expression of integrins α5 and β1 [53]. Notably, Grp2 is a SH3 domain containing protein 
that might bind to putative SH3 binding motifs in LMTK3. Moreover, Grp2 also binds to dynamin, a 











cell surface residency and therefore activity. A more detailed investigation of the interplay between 
LMTK3 and Grp2 receptor recycling will be instructive to elucidate the exact mechanism on how 
LMTK2 affects metastatic behaviour. 
 
On the other hand, Caswell et al have shown that blocking the adhesive cell properties 
promoted the simultaneous association of integrin α5/ β1 and EGFR1 to RCP resulting in coordinated 
PM recycling of this tri-partite receptor complex. This modified signaling downstream of EGFR1 
increased its autophosphorylation and resulted in the activation of the proinvasive kinase PKB/Akt 
 
[54]. Since RCP is a known LMTK3 substrate (see above) it together suggests that LMTK3 mediated 
phosphoregulation of endocytic recycling and LMTK3-dependent cross-talk affect transcription of 
integrin α5/ β1 contribute to cell migration. 
 
In a nuclear context, LMTK3 interacts with KRAB-associated protein 1 (KAP1), a master 
regulator of dynamic chromatin structure. LMTK3/KAP1 interaction was stabilised by protein 
 
phosphatase 1 . This complex suppressed KAP1 phosphorylation specifically at LMTK3-associated 
chromatin regions. Interaction led to transcriptional repression of tumour suppressor-like genes. 
Moreover, LMTK3 tethered chromatin to the nuclear periphery that resulted in gene silencing [11]. 
Therefore, nuclear LMTK3 acts as a scaffolding protein in chromatin reorganisation. 
 
Lastly, LMTK3 has been implicated in drug resistance insofar as its overexpression lead to 
changes in the transcription of numerous genes promoting DNA repair, cell viability and tumorigenesis 
processes / pathways in the breast cancer cell line MCF-7 [55]. In addition, in a subset of melanoma, the 
overexpression of LMTK3 overcame drug resistance in tyrosine kinase KIT mutations that led to KIT-
inhibitors induced drug resistance through the modulation of the translation rate of KIT [56]. 
 
Overall, LMTK family members have been heavily implicated in cancer insofar as they affect 
directly/indirectly numerous signalling pathways that impact cell behaviour. Whether LMTK 



















6. Conclusion and Outlook 
 
The family of LMTKs share multiple structural, functional and cell biological features. 
Moreover, current data reveal similarities in the regulation of LMTK kinase activities that will 
considerably extend over the coming years considering the number of in silico predicted 
phosphorylation sites. Based on available functional data, the hypothesis emerges that LMTKs 
regulate endosomal cargo recycling. In addition, LMTKs may shunt steroid receptors from the 
endocytic recycling pathway to the nucleus where they take part in receptor-specific gene 
transcription. If and how those two functions in recycling and nuclear transport, respectively, relate 
to each other will be a matter of future investigations. Functional mutations or deregulation of the 
expression of LMTK-family members result in a variety of pleiotropic downstream signalling defects 
that may corroborate neuropathological diseases, diverse cancers and other partly not yet 
acknowledged diseases. One of the challenges in the field will be to resolve the 3D structure of the 
kinase domain/regulatory segment in order to design modulators of LMTK functions. It is this 



































Figure1. Depicted is the overall structure of LMTK proteins. LMTK kinases are characterised by a N-
terminal signal peptide followed by a predicted transmembrane (TM) region with one or two 
transmembrane domains. LMTK1 occurs in an additional isoform in which the TM region is omitted 
by alternative splicing and membrane anchoring of the protein product is achieved through 
palmitoylation instead. A highly conserved kinase domain followed by a long C-terminal tail 
completes the primary structure. Embedded in the c-terminal tail LMTK3 features two poly-proline 
stretches (not shown in scheme) 
 
Figure2. Steady-state distribution of LMTKs LMTK1 and LMTK2 have both been attributed to the early 
 
(EE) and recycling endosomal (RE) pathways where they sequentially colocalise with Rab5 (EE), Rab11 and 
transferrin receptor (both RE), and myosin VI (EE). Although LMTK3 is present on cytoplasmic membranes 
its steady-state distribution has not yet been reported in detail. Additionally, LMTK2 has been localised to 
the plasma membrane and similar to LMTK3 also to the nucleus. 
 
Figure3. Similar functional competence of LMTKs in response to sex steroid ligands (SSLs) LMTK1A 
has not been brought into connection with SSLs. LMTK2 and LMTK3 have been implicated in 
androgen and estrogen receptor (AR and ER ) trafficking, respectively. It remains elusive whether 
either can be activated by the respective SSLs androgen and estrogen, respectively. LMTK1 and 
LMTK2 are both substrates for Cdk5/p35. Although predicted, LMTK3 has not yet been confirmed as 
a Cdk5 substrate with either p35 or p25 as Cdk5 coactivators. 
 
Figure4. Putative role of LMTK3 in ER trafficking ER has been identified as a potential substrate of 
LMTK3. In this hypothetical model, phosphorylated ER might prevent receptor degradation through 
Hsp27/Hsp90 chaparon binding and receptor palmitoylation (via PAT activity). Palmitoylated ER may 
subsequently bind to caveolin-1-positive vesicular structures resulting in either the recycling of 
 
ER where it can engage with estrogen ligand shunt  
 
ER  where it participates in a ligand-independent transcriptional response  
 
Alternatively, Hsp27/Hsp90 itself might be the phosphorylation target of LMTK3 triggering alternative 
 
ER          . Analogous pathways involving HSPs may exist for other steroid androgen  
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LMTK family of proteins comprises three kinase regulated serine/threonin 
kinases LMTK kinases regulate membrane trafficking/recycling and signalling 
 
Altered regulation/function of LMTKs leads to defects in cell development and can cause 
acquired drug resistance 
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